Smoking and smoking cessation treatments have a pharmacological impact on some commonly used drugs and should be taken into account during the selection, introduction and cessation of medicines.
Ensuring patients are optimised on maximum tolerated doses of medicines in heart failure with reduced ejection fraction is essential in minimising the burden of the condition.
Intravenous fluid managementSubscription
An introduction to fluid management for adults in hospitals, covering replacement during resuscitation, malnourished patients and following large electrolyte losses.
The evidence base supporting pharmacological and non-pharmacological interventions for nausea and vomiting after surgery.
An overview of the assessment process for acute upper gastrointestinal bleeding in the hospital setting and the treatment options available.
Palliative management in end-stage liver diseaseSubscription
Early palliative interventions, including reviewing regular medicines and managing common symptoms, enables patients to remain comfortable during end-of-life care.
An overview of the treatments for anaemia in chronic kidney disease and the tests needed to prescribe and assess their effectiveness.
Parkinson’s disease: management and guidanceSubscription
An overview of Parkinson’s disease management, including discussion of the updated National Institute for Health and Care Excellence guidelines.
An overview of management options for type 1 diabetes, the types of insulin, insulin regimens and strengths available for its day-to-day management as well as how to adjust doses and the role of carbohydrate counting and blood glucose monitoring.
Lung cancer: advances in management and therapySubscription
An overview of traditional and emerging immunotherapy-based targets and treatments available for lung cancer, their side effects and the impact immune checkpoint inhibitors have had on the treatment of non–small-cell lung cancer.
Refractory epilepsy: management in tertiary careSubscription
Epilepsy is a neurological disorder marked by sudden recurrent episodes of sensory disturbance, loss of consciousness or convulsions, associated with neurones exhibiting abnormally high electrical excitability in the brain.
As one of the most common paediatric psychiatric disorders, pharmacists and healthcare professionals need to be aware of the symptoms of depression and be able to assess children and young people who may be at risk.
Psoriasis is a complex, multifactorial, inflammatory disease associated with a significantly impaired quality of life. Around 80% of patients with plaque psoriasis have mild-to-moderate disease that is amenable to treatment in primary care, particularly through pharmacy, with topical therapies.
Hospital‑acquired pneumonia increases the length of in-patient hospital stay and is associated with high mortality rates, particularly in older people. Pharmacists and healthcare professionals need to know how to diagnose and manage the condition, and be cognisant of the gaps in the evidence base.
CLUSTER 1. Expert Professional Practice
CLUSTER 2. Collaborative Working Relationships
CLUSTER 1. Patient and Pharmaceutical Care
CLUSTER 2. Professional Practice Competencies
CLUSTER 3. Personal Practice Competencies